NCT00451386View on ClinicalTrials.gov

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

PHASE2CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Urinary Tract InfectionsBacterial PneumoniaSoft Tissue Infections

Interventions

DRUG

MK0826, ertapenem sodium /Duration of Treatment: 14 Days

DRUG

Comparator: ceftriaxone sodium /Duration of Treatment: 14 Days

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00451386 - Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036) | Biotech Hunter | Biotech Hunter